Tomeglovir
CAS: 233254-24-5
Ref. 3D-IJA25424
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
- Bay-38-4766
- N-[4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)phenyl]-3-hydroxy-2,2-dimethylpropanamide
Tomeglovir is a monoclonal antibody that has been designed to target the enzyme non-nucleoside polymerase. This drug is an oral prodrug that has been developed for the treatment of hepatitis B and C, as well as herpes simplex virus and influenza virus. Tomeglovir inhibits the RNA-dependent DNA polymerase of these viruses, which prevents them from replicating in cells. Tomeglovir also binds to human T-cell leukemia virus type 1 (HTLV-1) and blocks its reverse transcriptase, inhibiting viral replication. Tomeglovir is in phase II clinical trials for cancer and hepatitis C.
Chemical properties
Technical inquiry about: 3D-IJA25424 Tomeglovir
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
